S. 2944 · 108th Congress

A bill to provide that no funds may be expended by the United States Trade Representative to negotiate data exclusivity provisions for certain pharmaceutical products.

Stage
In committee
Sponsor
Ron Wyden
Introduced
2004-10-08
Latest action
2004-10-08 · Introduced in Senate

Action history

  1. 2004-10-08Introduced in Senate
  2. 2004-10-08Sponsor introductory remarks on measure.
  3. 2004-10-08Read twice and referred to the Committee on Finance.